Sunshine Biopharma Moves Principal Office to New York City
Sunshine Biopharma, Inc. (NASDAQ: 'SBFM') has relocated its headquarters to New York City while maintaining a satellite office in Montreal, Canada. The company operates a Canadian subsidiary with 41 employees and 51 generic prescription drugs on the market, planning to expand to 67 by 2024. Sunshine Biopharma is also conducting a proprietary drug development program for liver cancer and COVID-19. The press release contains forward-looking statements and emphasizes the risks and uncertainties involved in the company's activities.
12/04/2023 - 08:30 AM
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York City. The Company’s Head Office is now located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous headquarters in Montreal (Canada) at 6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, Quebec, Canada, H9R 0A5 (Tel: 514-426-6161). The Company’s email address (info@sunshinebiopharma.com ) and URL (www.sunshinebiopharma.com ) have not changed.
Ab o ut S u n s hi n e B i o p h a r m a
Sunshine Biopharma is a pharmaceutical company operating a Canadian wholly owned subsidiary (Nora Pharma Inc.) with 41 employees and 51 generic prescription drugs on the market in Canada. The Company is planning to expand its product offering to a total of 67 generic prescription drugs by the end of 2024. In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA for liver cancer, and (ii) PLpro protease inhibitor for COVID-19. For more information, please visit: www.sunshinebiopharma.com.
S af e Ha rb o r F o rw a r d - L oo k i ng St a t e m en t s
T h is p r e s s r ele a s e c on t a i n s f o r w a r d- l oo ki n g s t a tem en ts wh ich a r e ba s ed o n c u rr e n t e xp e c t a ti on s , f o r e ca s t s , a n d a ss u m p ti on s o f Sun s h i n e Bi o p ha r m a , In c. ( t h e “ C o m pan y”) t ha t i n v o lve r i s ks a s w e l l a s un c e r t a i n ties t ha t c ou ld c au s e a ct ua l o u tc o mes an d r es u lts to d iffer m a ter i a lly f r o m t ho s e an tici pa ted o r e xp e c te d . T h e s e s t a tem en ts app e a r in t h is r ele a s e an d i n cl ud e a ll s t a tem en ts t ha t a r e no t s t a tem en ts o f h i s t o r ic a l f a ct r e ga r d i n g t h e i n te n t, b elief o r c u rr e n t e xp e c t a ti on s o f t h e C o m p an y, i n cl ud i n g s t a tem en ts r el a ted to t h e C o m p an y ’ s d r u g d e v el o p me n t a ctivities, fi nan c i a l p erfo r m an c e , a n d f u t u r e g row t h . T h ese r i s ks an d un c e r t a i n ties a r e f u r t h er d esc r i b ed in fil i ng s an d r e po r ts b y t h e C o m pan y w ith t h e U .S . S e cu r i ties an d Ex cha n g e C o mmis s i o n (S E C ) . Act ua l r es u lts an d t h e timi n g o f c e r t a in e v e n ts c ou ld d iffer m a ter i a lly f r o m t h o s e p r o ject e d in o r c on tem p l a t ed b y t h e f o rw a r d - l oo ki n g s t a tem en ts du e to a nu m b er o f f a ct o r s d et a iled f r o m time to time in t h e C o m pan y ’ s fil i ng s w ith t h e S E C . Refere n ce is h ere b y m ad e to c au ti o n a r y s t a tem en ts an d r i s k f a ct o r s s et f o r th in t h e C o m pan y ’ s m o s t rec en t S EC fil i ng s .
F o r Add i t i o n a l I n fo r m at i o n:
Sunshine Biopharma Contact: Camille Sebaaly, CFO Direct Line: 514-814-0464 camille.sebaaly@sunshinebiopharma.com
Where is Sunshine Biopharma, Inc. headquartered now?
Sunshine Biopharma, Inc. is now headquartered in New York City.
What is the new address of Sunshine Biopharma, Inc.'s headquarters?
The new address of Sunshine Biopharma, Inc.'s headquarters is 1177 Avenue of the Americas, 5th Floor, New York, NY 10036.
How many generic prescription drugs does Sunshine Biopharma, Inc. have on the market in Canada?
Sunshine Biopharma, Inc. has 51 generic prescription drugs on the market in Canada.
What is Sunshine Biopharma, Inc.'s plan for expanding its product offering?
Sunshine Biopharma, Inc. plans to expand its product offering to a total of 67 generic prescription drugs by the end of 2024.
What drug development programs is Sunshine Biopharma, Inc. conducting?
Sunshine Biopharma, Inc. is conducting a proprietary drug development program for liver cancer and COVID-19.